HER2/CEP17 Ratio
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy (NCT07376174) | Shandong Cancer Hospital and Institute | 2026-01-10 |
Track HER2/CEP17 Ratio automatically
Every clearance here is in the API, with alerts when new ones post.